Scientific Symposium

Saturday, October 30, 2021

Co-Hosted by  AIM-HI logo
 

*Speakers subject to change

State-of-the-Art of Translational Research and Investments in Oncology

9:00 – 9:30 am:

Meet and Greet

9:30 – 9:40 am:

Welcoming Remarks

Web Cavenee, Ph.D.

Chair, National Foundation for Cancer Research Scientific Advisory Board

Emeritus Professor of Medicine, UCSD

Sujuan Ba, Ph.D.

CEO of National Foundation for Cancer Research & CEO and Co-Founder of AIM-HI Accelerator Fund

9:40 – 10:00 am:

Keynote Presentation

Doug Lowy, M.D.

Principal Deputy Director, NCI
“Preventing Cancer and Improving Treatment for Cancer Patients”

10:00 – 11:00 am:

Immunotherapy: State of the Art and Future Trends

Moderator: Steve Rosenberg, M.D., Ph.D.

Chief, Surgery Branch, NCI

 

Presentation by Suzanne Topalian, M.D.

Professor, Surgery and Oncology, Johns Hopkins University 

Assoc. Dir. Bloomberg-Kimmel Institute Cancer Immunotherapy
“Immune checkpoint blockade: unleashing the immune system against cancer”

Presentation by Scott Lippman, M.D

Director, Moores Cancer Center, University of California San Diego 

“Chromosome 9p loss drives immune evasion and checkpoint-inhibitor resistance in HPV— HNSC”

Panel Discussion:

Drew Pardoll, M.D., Ph.D.

Director, Bloomberg-Kimmel Institute for Cancer Immunotherapy Professor of Oncology, John Hopkins University

Jeremiah Johnson, Ph.D.

Professor, Department of Chemistry, MIT

John Schiller, Ph.D.

Deputy Chief, Laboratory of Cellular Oncology

Head, Neoplastic Diseases, NCI

Ben Yong, M.D.

Chief Medical Officer, BeiGene

11:00-11:15 am: Break

11:15 am – 12:15 pm:

Precision Medicine in Cancer

Moderator: Raju Kucherlapati, Ph.D.

Paul C. Cabot Professor of Genetics, Harvard Medical School   

 

Presentation by Jennifer Grandis, M.D.

American Cancer Society Professor; Professor, Otolaryngology – Head and Neck Surgery, University of California San Francisco
“Precision Head and Neck Cancer Medicine”

Presentation by Hai Yan, M.D., Ph.D.

Professor of Professor of Neuro-Oncology, Duke University School of Medicine; CSO and Co-Founder of GeneTron Health

 

Panel Discussion:

Ron DePinho, M.D.

Professor, Department of Cancer Biology, Past President

The University of Texas MD Anderson Cancer Center

Carlo Croce, M.D.

John W. Wolfe Chair in Human Cancer Genetics, The Ohio State University Comprehensive Cancer Center

Bruce Johnson, M.D.

Chief Clinical Research Officer, Dana-Farber Cancer Institute

Monica Bertagnolli, M.D.

Professor, Surgery, Harvard Medical School

 

12:15 - 3:00 pm: Break for Lunch

3:00 – 4:00 pm:

Investments in Oncology Startups: Opportunities and Challenges

Moderator: Jimmy Lu

Co-Founder, R3Bio    

Presentation by Tom Miller

Founder and Managing Partner, GreyBird Ventures

Panel Discussion:

Dimitra Georganopoulou, Ph.D.

Innovation – MIT linQ CATALYST | QRAL | Keiretsu Forum

Benjamin Chen, Ph.D.

Partner, Panaceas Venture

Catherine Pan

Partner, Dorsey & Whitney LLP

Fei Shen, Ph.D.

Managing Director, Boehringer Ingelheim Venture Fund USA

Srini Akkaraju, M.D., Ph.D.

Samsara BioCapital, Founder and Managing Partner

 

4:00 – 4:15 pm:

Closing Remarks

Web Cavenee, Ph.D.

Chair, National Foundation for Cancer Research Scientific Advisory Board, Emeritus Professor of Medicine, UCSD

Sujuan Ba, Ph.D.

CEO of National Foundation for Cancer Research

CEO and Co-Founder of AIM-HI Accelerator Fund

Special Thanks To Our Sponsors!

Sponsorship Opportunities

Inquiries regarding sponsorship of the October 30, 2021 event can be made by e-mail at info@nfcr.org or by phone at 1-301-961-9161.

Learn more here about the many marketing, business development, brand exclusivity, knowledge leadership, and goodwill generation benefits of sponsorship of the Day to Celebrate Progress in Cancer Research and Entrepreneurship.